Neuland Labs Shares Drop 5.3% in Pre-Open Trade After Q3 Results

Neuland Laboratories' shares fell 5.3% in pre-open trade on February 11, 2025, following the announcement of its Q3 FY25 results. Despite a 1.8% YoY revenue growth to ₹401.9 crore, EBITDA declined sharply by 26.4% YoY to ₹90.3 crore, with margins contracting to 22.5% from 31.1%. However, PAT rose by 25.6% YoY to ₹101.4 crore, driven by improved operational efficiencies. Investors reacted negatively to the margin pressures despite the company's optimistic outlook for long-term growth through capacity expansion and customer acquisition.

Sources: Trendlyne, MarketScreener, Economic Times